Clinical Trial Update: Effect of the Probiotic SF68® on Body Composition and Low-to-moderate Cardiovascular Risk [NA]

View source ↗

Summary

A completed clinical trial evaluating the probiotic SF68® for effects on body composition and cardiovascular risk in individuals with overweight or obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• SF68

Snippet

Sponsor: Azienda Ospedaliero-Universitaria Careggi | Conditions: Overweight and Obesity | NA | Status: COMPLETED